Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
Managing your workforce is continuously evolving and can be enhanced by technology that can improve efficiency and decrease costs. In the latest episode of...
Join A&M Managing Director, Debra Richman, as she talks with Marcus Osborne, SVP, Health & Wellness at Walmart to discuss healthcare strategy, the growth...
In this podcast, Larry Kaiser, M.D., FACS, Managing Director, and Marthe Haverkamp, Director, in A&M’s Healthcare Industry Group, spoke with Health System CEOs and...